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ABSTRACTSwere greater for trainees, yet overall failure did not reach signiﬁcance.
Mean warm ischaemic time for trainer and trainee were 63 and 65 mi-
nutes respectively (p>0.05). The highest proportion of cases were onco-
logical and traumatic reconstructions. No signiﬁcant difference between
microvascular complication/failure was observed between these sub-
groups.
Conclusion: Trainee failure rate in this large experience is comparable to
other unit experiences for senior surgeons. Moreover with appropriate
supervision success rates comparable to trainers is evident. In an erawhere
the trainee has limited exposure, skill acquisition may have to be targeted
through high volume cost effective units.
0973: SKIN CANCER DIAGNOSIS HIT OR MISS? THE LEICESTER
EXPERIENCE
Kwang Chear Lee, Rajshree Jayarajan, Maharukh Daruwalla. Leicester Royal
Inﬁrmary, Leicester, UK.
Introduction: Accurate clinical diagnosis of skin lesions aids in the pri-
oritisation of skin cancer treatment and avoids unnecessary excisions. Our
objective was to assess the accuracy of clinical diagnosis and compare the
accuracy across different specialities.
Methods: Data was collected retrospectively from histology reports ob-
tained following a trawl of all skin pathologies at Leicester Royal Inﬁrmary
between June and December 2011. Only malignant or pre-malignant skin
lesions were included. Clinical histories were compared to ﬁnal pathology
reports.
Results: 791 lesions were excised from 650 patients. 57.1 % of patients
were male, and mean age was 72 years. Overall, clinical diagnosis was
correct in 82.4% of cases. 91% of BCCs and 77% of SCCs were diagnosed
correctly preoperatively but only 70% of malignant melanomas had accu-
rate pre-operative diagnoses. Dermatologists were most likely to correctly
diagnose a malignant/pre-malignant skin lesion correctly (84.7%), fol-
lowed by Plastic surgeons (86.2%) with no signiﬁcant difference between
these 2 groups (p¼0.707). General practitioners however had a signiﬁ-
cantly lower accuracy of 60.1% (p<0.0001).
Conclusions: Our overall rate of accurate clinical diagnosis is comparable
to other studies however intervention is required to improve the rate of
melanoma identiﬁcation and the ability of general practitioners in recog-
nising malignant skin cancers.
0995: THE USE OF BLOOD PRODUCTS IN FREE FLAP BASED BREAST
RECONSTRUCTION e A COST AND SAFETY ANALYSIS
Christopher Macdonald, William Reeve, Anita Hazari. Queen Victoria
Hospital, East Grinstead, UK.
As surgeons we are under increasing pressure to improve efﬁciency and
cost saving without negatively impacting on the quality and safety of our
patient's care. Published rates of red cell transfusion in free ﬂap based
breast reconstruction range widely (18-80%). We felt that our transfusion
rates were low enough that routinely crossmatching blood was likely to be
a poor use of resources.
We retrospectively reviewed a year of free ﬂap based breast reconstruction
activity at a regional centre. There had been 141 free ﬂaps performed on 130
patients. One patient received an elective pre-operative platelet transfusion
and ﬁve patients received red cell transfusions (5/130, 3.8%). Two patients
received blood intra-operatively whilst the rest received red cells over days
1 to 4 post-op. None of the patients had abnormal antibodies and all could
have safely received universal donor (O negative) blood.
124 patients had blood needlessly cross matched at signiﬁcant expense.
The patients that did require transfusion could either have received uni-
versal donor blood or have safely waited for blood to be cross matched. We
would encourage other departments to review their practice as a potential
area for improving cost efﬁciency without any additional increase in risk.
1184: ATYPICAL FIBROXANTHOMA: 10 YEAR SURGICAL EXPERIENCE, DO
WE NEED GUIDELINES
Amir Sadri, Debbie Hunt, Leila Touil, Ahmed El Gawad, Mohammed Maher,
Ali Juma. Countess Of Chester Hospital, Chester, UK.
Introduction: Atypical ﬁbroxanthoma (AFX) is a malignant derma tumour.
A lack of appreciation for this tumour can lead to loss to follow-up and lack
of treatment. No guidelines exist for the management of AFX. We present
our 10 year experience with these malignant tumours of the skin.Methods: A retrospective review of all cases of AFX was performed be-
tween 2002 to 2012. The following outcomes; location of lesion, method of
biopsy, excisionmargin, total follow-up period, metastases, recurrence and
time to recurrence and ﬁnally deaths were recorded.
Results: Thirty-three cases of AFX were treated between 2002-12. The
scalp (67%) was the commonest site and predominated in elderly male
individuals (90.9%). Biopsy was performed in 30% of cases. Three percent of
biopsy proven AFX did not go on to have formal excision. Four lesions (12%)
were incompletely excised. The recurrence in incompletely excised cases
was 50% and 6.1% overall. 18% of patients were discussed at an MDT. No
deaths were recorded.
Conclusion: This is the largest UK series of AFX. It shows similar man-
agement issues that other series have described such as lack of follow-up,
incomplete excision without re-excision and lack of MDT discussion.1244: COMMUNICATING THE LOCATION OF POTENTIAL SKIN NEO-
PLASMS FOR EXCISION BETWEEN THE REFERRING AND THE OPER-
ATING DOCTOR e AN AUDIT OF SKIN LESION REFERRALS IN
WHANGANUI, NEW ZEALAND
Naomi Bullen, Fraser Welsh, Semisi Aiono.Whanganui Hospital, Whanganui,
New Zealand.
Introduction: Melanoma and non-melanoma skin cancer are widely
prevalent in New Zealand. A clear referral letter is essential to correctly
deﬁne the location of potential skin cancer requiring surgical treatment.
Methods: Information localising target lesions for patients seen in the
local anaesthetic theatre in Whanganui Hospital New Zealand was recor-
ded during a two month period (April-May 2012 inclusive). The surgical
department and referring GPs were then educated regarding improve-
ments to the referral process. The audit cycle was then completed
(September-October 2012 inclusive).
Results: There were 100 patients in the primary study and 76 in the re-
audit. The number of patients whose lesion was not identiﬁable from the
referral letter decreased from 30% to 23.7%. The number of patients whose
lesion could not be identiﬁed by either referral letter or patient themselves
fell to 9.2% from 13%. There was an increase in inclusion of photographs
from 3.0% to 9.3%
Conclusions: Use of photographic referral for suspicious skin lesions is
under-utilised in our service. Relying on the patient or the referral text to
correctly identify the lesion leaves room for error. The second audit shows
small improvements but further education is needed to meet our target of
pictorial localisation with each referral.1279: RE-EXCISION OF BCCS WITH POSITIVE HISTOLOGICAL MARGINS e
IS THIS NECESSARY?
Victor Ki-Shing Miu, Dua Saeed, Jasmine Tang, Paolo Matteucci. Castle Hill
Hospital, Hull, UK.
Most BCCs are treated with excision although depending on the nature of
the lesions, other treatmentmodalities can be used. The British Association
of Dermatologists issued a guideline in 2008 for the management of BCCs.
It is suggested that all BCCs with positive margins will needed to be treated
by re-excision.
Methods: Retrospective case-note analysis of all BCCs excised over a one-
year-period in our unit.
Results: 745 procedures were performed. 51 out of 86 incomplete BCC
excisions received re-excision. 53% of all re-excision specimens had no
residual BCCs. However, with high risk histological subtypes, the negative
re-excision rates decrease to 47%. In the low risk histological subgroup,
specimens contained no residual BCCs in 80% of the cases of re-excision. 15
high risk BCCs with positivemargins were treated conservatively; of which
3 had a recurrence of their BCCs (20%). In low risk subtype all 9 patients
receiving conservative treatment, have no evidence of recurrence to date.
Conclusion: Large numbers of re-excision specimens for ‘positive margin’
BCCs, contained no residual BCC. This is especially true in the low risk
subtype BCC. However, each patient should be assessed on a case by case
basis and offered re-excision or surveillance where appropriate.1283: TETANUS IMMUNISATION: DOCUMENTATION AND MANAGEMENT
Jurga Pikturnaite, Margarita Moustaki, Jamil Ahmed, Matthew James. Guys
and St Thomas NHS Foundation Trust, London, UK.
